164 related articles for article (PubMed ID: 32664121)
1. Upregulation of lncRNA plasmacytoma variant translocation 1 predicts poor prognosis in patients with muscle-invasive bladder cancer.
Li B; Guo LH; Ban ZQ; Liu L; Luo L; Cui TY
Medicine (Baltimore); 2020 Jul; 99(28):e21059. PubMed ID: 32664121
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance and Diagnostic Value of Overexpressed lncRNA PVT1 in Colorectal Cancer.
Pan X; Cheng R; Zhu X; Cai F; Zheng G; Li J; Gao C
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850702
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.
Yuan CL; Li H; Zhu L; Liu Z; Zhou J; Shu Y
Neoplasma; 2016; 63(3):442-9. PubMed ID: 26925791
[TBL] [Abstract][Full Text] [Related]
4. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
[TBL] [Abstract][Full Text] [Related]
5. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1.
Tian Z; Cao S; Li C; Xu M; Wei H; Yang H; Sun Q; Ren Q; Zhang L
J Cell Physiol; 2019 Apr; 234(4):4799-4811. PubMed ID: 30317572
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer.
Zhang J; Zhou X; Ding H; Wang L; Liu S; Liu Y; Chen Z
BMC Urol; 2020 Mar; 20(1):31. PubMed ID: 32192483
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X
Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406
[TBL] [Abstract][Full Text] [Related]
11. High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
Wang JF; Gong YQ; He YH; Ying WW; Li XS; Zhou XF; Zhou LQ
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6605-6615. PubMed ID: 32633349
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of long non-coding RNA plasmacytoma variant translocation1 in human solid tumors: A meta-analysis.
Zou B; Wang D; Xu K; Liu JL; Yuan DY; Meng Z; Zhang B
Medicine (Baltimore); 2019 Jul; 98(27):e16087. PubMed ID: 31277104
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA PVT1 as a novel potential biomarker for predicting the prognosis of colorectal cancer.
Fan H; Zhu JH; Yao XQ
Int J Biol Markers; 2018 Nov; 33(4):415-422. PubMed ID: 29888675
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancer.
Uysal D; Kowalewski KF; Kriegmair MC; Wirtz R; Popovic ZV; Erben P
PLoS One; 2021; 16(3):e0248342. PubMed ID: 33711044
[TBL] [Abstract][Full Text] [Related]
15. High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancer.
Nitschke K; Worst TS; von Rhade SM; Thaqi B; Neuberger M; Wessels F; Weis CA; Porubsky S; Gaiser T; Kriegmair M; von Hardenberg J; Weidenbusch M; Erben P; Nuhn P
Urol Oncol; 2021 Aug; 39(8):499.e1-499.e8. PubMed ID: 34134925
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the lncRNA PVT1 is associated with poor prognosis in pancreatic cancer patients.
Huang C; Yu W; Wang Q; Cui H; Wang Y; Zhang L; Han F; Huang T
Minerva Med; 2015 Jun; 106(3):143-9. PubMed ID: 25668599
[TBL] [Abstract][Full Text] [Related]
17. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence.
Zhang S; Zhong G; He W; Yu H; Huang J; Lin T
J Urol; 2016 Oct; 196(4):1270-8. PubMed ID: 27267320
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J
Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158
[TBL] [Abstract][Full Text] [Related]
19. A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable.
van Kessel KE; van de Werken HJ; Lurkin I; Ziel-van der Made AC; Zwarthoff EC; Boormans JL
PLoS One; 2017; 12(3):e0174039. PubMed ID: 28319171
[TBL] [Abstract][Full Text] [Related]
20. A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify
Shen D; Zhang Y; Zheng Q; Yu S; Xia L; Cheng S; Li G
DNA Cell Biol; 2021 Jan; 40(1):26-35. PubMed ID: 33270518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
